Ramkhamhaeng Hospital PCL (BKK:RAM) 5-Year EBITDA Growth Rate: 1.70% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:RAM Ramkhamhaeng Hospital PCL BKK:RAM
77 GF Score
Price ฿17.90
GF Value ฿45.41
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Ramkhamhaeng Hospital PCL 5-Year EBITDA Growth Rate?

Ramkhamhaeng Hospital PCL BKK:RAM -0.56% 77 5-Year EBITDA Growth Rate is 1.70% as of Mar. 2026. GuruFocus rates BKK:RAM with a GF Score™ of 77/100 and a GF Value™ of ฿45.41 (Possible Value Trap). The stock has 6 warning signs investors should review.

Ramkhamhaeng Hospital PCL's EBITDA per Share for the three months ended in Mar. 2026 was ฿0.93.

During the past 12 months, Ramkhamhaeng Hospital PCL's average EBITDA Per Share Growth Rate was 147.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ramkhamhaeng Hospital PCL was 35.80% per year. The lowest was -30.30% per year. And the median was 11.50% per year.

Ramkhamhaeng Hospital PCL  (BKK:RAM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Ramkhamhaeng Hospital PCL 5-Year EBITDA Growth Rate Related Terms

BKK:RAM vs HCA, THC, DVA: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ramkhamhaeng Hospital PCL 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate falls into.


BKK:RAM
77GF Score
Ramkhamhaeng Hospital PCL BKK:RAM
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramkhamhaeng Hospital PCL 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 1.70% mean?
Ramkhamhaeng Hospital PCL (BKK:RAM) has a 5-Year EBITDA Growth Rate of 1.70% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ramkhamhaeng Hospital PCL and its competitors.
Is Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate too high?
Ramkhamhaeng Hospital PCL's current 5-Year EBITDA Growth Rate is 1.70%. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate compare to HCA and THC?
Ramkhamhaeng Hospital PCL's 5-Year EBITDA Growth Rate of 1.70% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Ramkhamhaeng Hospital PCL and its competitors. Ramkhamhaeng Hospital PCL's current 5-Year EBITDA Growth Rate is 1.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿45.41, compared to a current price of ฿17.90 — trading 60.6% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 1.70%. Ramkhamhaeng Hospital PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current 5-Year EBITDA Growth Rate is 1.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?

Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued. The current stock price of ฿17.90 is trading 60.6% below its estimated GF Value™ of ฿45.41. GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.

Key valuation signals for BKK:RAM:

  • 5-Year EBITDA Growth Rate: 1.70%
  • GF Value™: ฿45.41 vs. price of ฿17.90 (60.6% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramkhamhaeng Hospital PCL Business Description

Address 436 Ramkhamhaeng Road, Kwaeng Huamark, Khet Bangkapi, Bangkok, THA, 10240
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
77GF Score

Get the complete analysis for BKK:RAM

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿17.90
Price
฿45.41
GF Value